Immunotherapy Biomarker Predicts Lung Cancer Response and Survival

Targeted immune system–modifying therapies have seen a massive spike in attention recently—as these immunotherapies have been successful in helping patients that were intractable to other, more common treatments. Although successful, immunotherapies do not work for everyone and investigators continually seek to identify which patient populations to target. Now, researchers supported by the Swiss National Science Foundation (SNSF) have discovered how to better predict who will respond